Logo Lucerna-Chem
+41 41 420 9636

Article Status


Catalog Number Pack Size List Price* Promo Price* Quantity
HY-114491-5MG 5 mg 477,00 405,50 Add
HY-114491-10MMO 10 mM * 1 mL 608,00 516,80 Add
HY-114491-10MG 10 mg 810,00 688,50 Add
HY-114491-25MG 25 mg 1'485,00 1'262,30 Add

* CHF, excl. 7.7% VAT and shipping costs

Product Description

Rineterkib (compound B) is an orally active RAF and ERK1/2 inhibitor in the study of a proliferative disease characterized by activating mutations in the MAPK pathway. The activity is particularly related to the treatment of KRAS-mutant NSCLC, BRAF-mutant NSCLC, KRAS-mutant pancreatic cancer, KRAS-mutant colorectal cancer (CRC) and KRAS-mutant ovarian cancer.

Category Biochemicals
Supplier MedChem Express
Application Cancer-Kinase/protease
Regulatory Status RUO
Format Solubility: DMSO : 200 mg/mL (345.77 mM; Need ultrasonic)
Grade Clinical information: No Development Reported
Molecular Formula C26H27BrF3N5O2
Molecular Weight 578....
CAS-Number [1715025-32-3]
Storage Conditions Please store the product under the recommended conditions in the Certificate of Analysis.
Product Line Research
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Material Safety Data Sheet Download PDF
Call us

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56

Business Hours
From Monday through Friday
08:00 – 12:00
13:00 – 17:00

Ask us

Technical Support

Business Development

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern


If you have already subscribed to our newsletter and would like to update your details or cancel it, please click here.

© Copyright 2021 Lucerna-Chem AG, Switzerland